Literature DB >> 10200984

Mutational analysis within the 3' region of the PKD1 gene.

C Badenas1, R Torra, J L San Millán, L Lucero, M Milà, X Estivill, A Darnell.   

Abstract

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common genetic diseases in humans, affecting 1 out of 1000 individuals. At least three different genes are involved in this disease. The search for mutations in PKD1 is complicated because most of the transcript is encoded by a genomic region reiterated more proximally on chromosome 16, and no prevalent mutation has been reported.
METHODS: We have screened DNA from exon 43 through exon 46 and intron 40 of the PKD1 sequence by single-stranded conformational polymorphism (SSCP) analysis in 175 ADPKD patients.
RESULTS: We have found 25 differences with respect to the reported PKD1 DNA sequence, seven of which are mutations (Q4041X, Q4124X, IVS44-1G-->C, IVS45-1G-->A, 12801del28, R4275W, and Q4224P). We found different phenotypical expressions of the same mutation in the families studied. We have detected several common polymorphisms, and some of them cosegregate, suggesting a common origin of these alleles in PKD1.
CONCLUSIONS: The detection of only seven mutations in 175 unrelated ADPKD patients for this region of the PKD1 analyzed suggests that mutations could be widespread throughout all of the gene and that a prevalent mutation is not expected to occur. The identified PKD1 missense mutations may help to refine critical regions of the protein. Until a quicker and more sensitive method for the detection of mutations becomes available, linkage studies will continue to be the basis for the molecular diagnosis of ADPKD families.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10200984     DOI: 10.1046/j.1523-1755.1999.00368.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation.

Authors:  J To-Figueras; C Badenas; C Carrera; C Muñoz; M Milá; M Lecha; C Herrero
Journal:  J Inherit Metab Dis       Date:  2006-08       Impact factor: 4.982

2.  Regulation of polycystin-1 ciliary trafficking by motifs at its C-terminus and polycystin-2 but not by cleavage at the GPS site.

Authors:  Xuefeng Su; Maoqing Wu; Gang Yao; Wassim El-Jouni; Chong Luo; Azadeh Tabari; Jing Zhou
Journal:  J Cell Sci       Date:  2015-10-01       Impact factor: 5.285

3.  Polycystin-1 regulates actin cytoskeleton organization and directional cell migration through a novel PC1-Pacsin 2-N-Wasp complex.

Authors:  Gang Yao; Xuefeng Su; Vy Nguyen; Kristina Roberts; Xiaogang Li; Ayumi Takakura; Markus Plomann; Jing Zhou
Journal:  Hum Mol Genet       Date:  2014-01-02       Impact factor: 6.150

4.  Analysis of the cytoplasmic interaction between polycystin-1 and polycystin-2.

Authors:  Jozefina Casuscelli; Stefan Schmidt; Brenda DeGray; Edward T Petri; Andjelka Celić; Ewa Folta-Stogniew; Barbara E Ehrlich; Titus J Boggon
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-02

5.  High Resolution Melt analysis for mutation screening in PKD1 and PKD2.

Authors:  Stanislas Bataille; Yvon Berland; Michel Fontes; Stéphane Burtey
Journal:  BMC Nephrol       Date:  2011-10-18       Impact factor: 2.388

6.  Biogenesis of mammalian microRNAs by a non-canonical processing pathway.

Authors:  Mallory A Havens; Ashley A Reich; Dominik M Duelli; Michelle L Hastings
Journal:  Nucleic Acids Res       Date:  2012-01-23       Impact factor: 16.971

7.  Protein phosphatase-1α interacts with and dephosphorylates polycystin-1.

Authors:  Stephen C Parnell; Sanjeev Puri; Darren P Wallace; James P Calvet
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

8.  New mutations in the PKD1 gene in Czech population with autosomal dominant polycystic kidney disease.

Authors:  Jitka Stekrova; Jana Reiterova; Stanislava Svobodova; Vera Kebrdlova; Petr Lnenicka; Miroslav Merta; Ondrej Viklicky; Milada Kohoutova
Journal:  BMC Med Genet       Date:  2009-08-17       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.